Contributed By Walder Wyss Ltd
Information on unauthorised medicines during a scientific conference directed at healthcare professionals can be provided. However, no promotion for such medicines is allowed. The same applies to new indications, possible applications, dosages, pharmaceutical forms and packings of a medicine. With such information, it must always be clearly stated that this medicine, or the new indication, possible application, dosage, pharmaceutical form or packing for the medicine has not yet received marketing authorisation from Swissmedic (Article 32 paragraph. 1 lit. c HMG; Article 5 paragraph 1 AWV; rules 241 and 242 Pharma Code).